StreetAlpha.app
Home › Stocks › MRVI

Maravai Lifesciences Holdings, Inc. (MRVI)

Healthcare
$6.98
▼ −2.92%
LAST CLOSE · NOV 20

Maravai LifeSciences makes nucleic acid products and bioprocess testing kits and services for drug developers and researchers. It last closed at $6.98 on Nov 20, down 2.92% on the day. The next earnings report for MRVI is expected around Thu, Feb 4, 2027, after the close. For the quarter ended Sep 2026, MRVI reported EPS of -$0.09 on revenue of $45.9M, with revenue up 10.1% from a year ago. Over its last 8 reports the stock moved an average of 13.7% the session after earnings. Over the last 12 months MRVI insiders bought $369K of stock on the open market and sold $254K, according to SEC Form 4 filings.

AI Auto Pilots
Is MRVI in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold MRVI.

Key Stats

Last 12 months
Results
Revenue
$213.0M
+10.7% vs a year ago
Net income
−$65.7M
−30.8% margin
EPS (diluted)
−$0.44
Free cash flow
−$13.3M
−6.2% margin
Balance sheet
Cash & equivalents
$73.0M
At Sep 30
Debt
$147.2M
At Sep 30
Shareholder equity
$195.9M
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $799.2M$799.2MFY2021FY2022: $883.0M$883.0MFY2022FY2023: $288.9M$288.9MFY2023FY2024: $259.2M$259.2MFY2024FY2025: $185.7M$185.7MFY2025

From MRVI's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Feb 4
Estimated date · After the close
Reported EPS
-$0.09
Quarter ended Sep 2026
Year ago EPS
-$0.18
Same quarter last year
Revenue
$45.9M
+10.1% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.18Dec '24Mar 2025: -$0.21Mar '25Jun 2025: -$0.27Jun '25Sep 2025: -$0.18Sep '25Dec 2025: -$0.24Dec '25Mar 2026: -$0.02Mar '26Jun 2026: -$0.08Jun '26Sep 2026: -$0.09Sep '26Latest -$0.09
Revenue by quarter
Dec 2024: $56.6MDec '24Mar 2025: $46.9MMar '25Jun 2025: $47.4MJun '25Sep 2025: $41.6MSep '25Dec 2025: $49.9MDec '25Mar 2026: $65.8MMar '26Jun 2026: $51.4MJun '26Sep 2026: $45.9MSep '26Latest $45.9M
How MRVI moved after its last 8 reports
Average move the session after a report ±13.7%
Aug 6, 2026After the close−0.3%
May 7, 2026After the close+23.1%
Feb 25, 2026After the close+9.2%
Nov 6, 2025After the close−0.7%
Aug 11, 2025After the close+30.6%
May 12, 2025After the close−2.8%
Feb 25, 2025Before the open−21.7%
Jan 8, 2025After the close−20.9%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on MRVIStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on MRVI
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on MRVI

Technical Analysis

MRVI · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend

The stock is 9% below its 20 day and 6% below its 50 day average. It is 21% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 43). The nearest support is the Pivot S1 at $6.87, and the nearest resistance the Pivot at $7.02.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 6.9%/day
Key levels
$9.4252 week high+35.0%
$7.6320 day average+9.3%
$7.44Swing high (Jul 23)+6.6%
$7.4350 day average+6.4%
$7.13100 day average+2.1%
$7.13Pivot R1+2.1%
$7.02Pivot+0.6%
$6.98Last close
$6.87Pivot S1−1.6%
$6.80Swing low (Nov 5)−2.6%
$5.53200 day average−20.8%
$2.8052 week low−59.9%
Indicators
RSI (14)43.11Middle of its rangeNeutral
MACD-0.06Below its signal lineBearish
Stochastic25.3Middle of its rangeNeutral
ADX (14)10.8No clear trend
Williams %R-87.0Oversold below −80, overbought above −20Oversold
CCI (20)-133.0Oversold below −100, overbought above 100Oversold
Rate of change−7.2%Change over 10 sessionsBearish
ATR (14)$0.48Typical daily range, 6.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for MRVI

What happened before

See how MRVI did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow MRVI usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How MRVI has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for MRVIHow many large options trades hit MRVI, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

MRVI Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲123 buying vs 82 selling
  • ▲Shares held by funds +1.0%
  • ▲Funds holding +23
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding203180+12.8%
In funds' top 1024−50.0%
Held by funds–––
New / increased52 / 7146 / 56+20.6%
Reduced / sold out53 / 2952 / 23+9.3%
Put/call ratio0.000.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See MRVI institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

MRVI Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$369K1 buy · 1 insider
Sold$254K1 sale · 1 insider
100% of the selling was under pre-arranged trading plans.
Cluster buy: 2 insiders bought $1.9M between Nov 11 and Dec 8.
2025-12 bought $369K2026-06 sold $254KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Jun 10Kurt OreshackGeneral CounselSale plan50,000$5.08$254K
Dec 8, 2025Gregory T LucierDirectorBuy100,000$3.69$369K
Nov 13, 2025Bernd BrustCEOBuy216,212$3.25$703K
Nov 12, 2025Bernd BrustCEOBuy250,559$3.23$809K
Jan 31, 2025Kurt OreshackGeneral CounselSale plan25,000$5.03$126K
Nov 12, 2024John A DeFordDirectorBuy17,500$5.75$101K
Every insider buy and sale for MRVI over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See MRVI insider trades →

From SEC Form 4 filings by MRVI's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MRVI is in one of them and how their past MRVI trades turned out.

MRVI in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered MRVI in an article yet. Here's the latest on the wider market.

MRVI Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed May 19
Who traded MRVI · since 2023
Latest 1 filing
$1K – $15KTraded Apr 10, 2023Filed May 19, 2023
PersonTypeAmountTradedFiledDelay
Dan GoldmanD · NYSell$1K – $15KApr 10, 2023May 19, 202339 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Maravai Lifesciences Holdings

Maravai LifeSciences is a life sciences company based in San Diego, California. Its TriLink segment makes modified nucleic acids for customers' research, therapeutic and vaccine programs, and sells research products for labeling and detecting proteins in cells and tissue samples. Its Cygnus segment sells kits and products for testing biologic drug manufacturing, including host cell protein and impurity detection and viral clearance prediction, and offers services such as custom antibody development and mass spectrometry. Its customers include drug developers, vaccine makers, researchers and biologic drug manufacturers.

Headquarters
San Diego, CA